Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Return on Capital Employed (2016 - 2025)

Editas Medicine (EDIT) has disclosed Return on Capital Employed for 10 consecutive years, with 1.38% as the latest value for Q3 2025.

  • Quarterly Return on Capital Employed fell 57.0% to 1.38% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1.38% through Sep 2025, down 57.0% year-over-year, with the annual reading at 0.73% for FY2024, 35.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 1.38% at Editas Medicine, up from 1.4% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.24% in Q1 2021, with the low at 1.4% in Q2 2025.
  • Average Return on Capital Employed over 5 years is 0.63%, with a median of 0.48% recorded in 2023.
  • The sharpest move saw Return on Capital Employed rose 14bps in 2021, then tumbled -77bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.24% in 2021, then crashed by -103bps to 0.49% in 2022, then increased by 21bps to 0.39% in 2023, then tumbled by -153bps to 0.98% in 2024, then plummeted by -41bps to 1.38% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 1.38%, 1.4%, and 1.13% for Q3 2025, Q2 2025, and Q1 2025 respectively.